{"id":"W2892305705","doi":"10.1002/ajh.25273","title":"A dose‐ranging study of ticagrelor in children aged 3‐17 years with sickle cell disease: A 2‐part phase 2 study","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"AstraZeneca","keywords":"Ticagrelor; Medicine; Dosing; Adverse effect; Myocardial infarction; Placebo; Internal medicine; Acute coronary syndrome; Platelet; Pharmacology; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002889735,0.0001546566,0.0008313861,0.0003394894,0.00004106296,0.000005211485,0.0001429647,0.00003160503,0.00007868699],"category_scores_gemma":[0.00005280538,0.0001096584,0.00007931219,0.0005521777,0.000414956,0.00004711905,0.00003456457,0.0003367871,0.00000712064],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002662594,"about_ca_system_score_gemma":0.0001809755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001166294,"about_ca_topic_score_gemma":0.00003120574,"domain_scores_codex":[0.9984329,0.00018082,0.0006123608,0.0001908537,0.0002970578,0.0002859847],"domain_scores_gemma":[0.9988208,0.00006169526,0.0005258461,0.0002566134,0.0001220291,0.0002130344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004660053,0.01310738,0.964748,0.00002215142,0.0005507296,0.002138148,0.009830918,0.00002280443,0.0001465998,0.000005152311,0.0005800248,0.004188104],"study_design_scores_gemma":[0.04657153,0.06596917,0.8073138,0.0003527518,0.001289136,0.002580696,0.07524808,0.00005182536,0.0001611116,0.00001447064,0.0001377129,0.0003096928],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998655,0.0003260722,0.00002536841,0.0002085614,0.00005424834,0.000600868,0.000002035627,0.00001006118,0.0001178413],"genre_scores_gemma":[0.9995575,0.00002312563,0.0001742502,0.0001245048,0.00005440465,0.000005856682,0.000001336844,0.00002378221,0.00003521689],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1574341,"threshold_uncertainty_score":0.4471738,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005830681435395879,"score_gpt":0.2717543100705577,"score_spread":0.2659236286351618,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}